Nickel-2,3,7,8,I2,I3,I7,I&uctaacetic acid-5,10, I5,20-tetra-[3cahmmyl-methoxyphe@rporphyrin octamethylester (NITCP) was given in a Cremophor EL, a polyethowylated castor oil, and propylene glycol emulsion to B A W c mice bearing transplanted S.C. KHJJ mammary carcinomas. A total dose of 244 pg NiTCP
Boron neutron capture therapy: A mechanism for achieving a concomitant tumor boost in fast neutron radiotherapy
β Scribed by George E. Laramore; Peter Wootton; John C. Livesey; Donald S. Wilbur; Rudi Risler; Mark Phillips; Jon Jacky; Thomas A. Buchholz; Thomas W. Griffin; Stanley Brossard
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 1010 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The resurgence of interest in neutron capture therapy, which uses boron-10 labelled compounds and neutron irradiation as a technique for the treatment of cancer, has been accompanied by the application of a new generation of techniques for the analysis and imaging of boron in biological matrices. In
## Abstract ## Background. We describe the first case of extensive squamous cell carcinoma in the temporal bone recurring after surgery, conventional radiotherapy, and chemotherapy, which was treated using planned fractionated boron neutron capture therapy (BNCT). ## Methods. A 42βyearβold patie